Format

Send to

Choose Destination
Am J Transplant. 2015 Jun;15(6):1615-22. doi: 10.1111/ajt.13223. Epub 2015 Mar 24.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Author information

1
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC.
2
Center for Human Genomics & Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC.
3
Division of Nephrology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
4
Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
5
Division of Nephrology, Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN.
6
Minneapolis Medical Research Foundation, Minneapolis, MN.
7
General Surgery & HLA Immunogenetics Lab, Wake Forest School of Medicine, Winston-Salem, NC.
8
Alabama Regional Histocompatibility Laboratory at UAB, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
9
Department of Pathology & Lab Medicine, Emory School of Medicine, Atlanta, GA.
10
Department of Surgery, Duke University School of Medicine, Durham, NC.
11
Department of General Surgery, Wake Forest School of Medicine, Winston-Salem, NC.
12
Division of Nephrology, Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY.
13
Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC.

Abstract

Apolipoprotein L1 gene (APOL1) nephropathy variants in African American deceased kidney donors were associated with shorter renal allograft survival in a prior single-center report. APOL1 G1 and G2 variants were genotyped in newly accrued DNA samples from African American deceased donors of kidneys recovered and/or transplanted in Alabama and North Carolina. APOL1 genotypes and allograft outcomes in subsequent transplants from 55 U.S. centers were linked, adjusting for age, sex and race/ethnicity of recipients, HLA match, cold ischemia time, panel reactive antibody levels, and donor type. For 221 transplantations from kidneys recovered in Alabama, there was a statistical trend toward shorter allograft survival in recipients of two-APOL1-nephropathy-variant kidneys (hazard ratio [HR] 2.71; p = 0.06). For all 675 kidneys transplanted from donors at both centers, APOL1 genotype (HR 2.26; p = 0.001) and African American recipient race/ethnicity (HR 1.60; p = 0.03) were associated with allograft failure. Kidneys from African American deceased donors with two APOL1 nephropathy variants reproducibly associate with higher risk for allograft failure after transplantation. These findings warrant consideration of rapidly genotyping deceased African American kidney donors for APOL1 risk variants at organ recovery and incorporation of results into allocation and informed-consent processes.

KEYWORDS:

clinical research / practice; donors and donation: deceased; genetics; genomics; kidney disease; kidney transplantation / nephrology; molecular biology; translational research / science

PMID:
25809272
PMCID:
PMC4784684
DOI:
10.1111/ajt.13223
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center